台股 » 個股 » 高端疫苗 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

高端疫苗

(6547)
  • 股價
    49.05
  • 漲跌
    ▼0.65
  • 漲幅
    -1.31%
  • 成交量
    1,295
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 714人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
高端疫苗 (6547)籌碼相關-大昌-新店 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

大昌-新店 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/212.150.7000.0049.702.12,1070.10%
2025/01/201649.512549.3050.00-92,088-0.43%
2025/01/17148.10648.3347.95-52,050-0.24%
2025/01/16248.0500.0047.6022,0300.10%
2025/01/150.550.30150.2049.55-0.51,978-0.03%
2025/01/149.549.964350.2250.40-33.51,765-1.90%
2025/01/13748.19649.2849.3011,2640.08%
2025/01/1000.00544.8544.85-5950-0.53%
2025/01/0900.00639.8740.80-6923-0.65%
2025/01/08137.35136.9037.1008180.00%
2025/01/07235.6000.0035.5527730.26%
2025/01/0600.00235.7335.50-2785-0.25%
2025/01/03135.5000.0035.2017910.13%
2024/12/3000.00137.5037.15-1790-0.13%
2024/12/2700.00138.3037.60-1785-0.13%
2024/12/26238.33136.3038.1017540.13%
2024/12/24136.95136.8036.6507220.00%
2024/12/17134.1000.0034.1016850.15%
2024/12/1300.00634.4634.35-6687-0.87%
2024/12/11337.10135.6035.8026720.30%
2024/12/09137.7500.0037.8516680.15%
2024/12/0300.00138.5038.45-1668-0.15%
2024/11/2800.00039.1538.9006810.00%
2024/11/2500.000.538.4038.50-0.5653-0.07%
2024/11/20137.5500.0037.4516560.15%
2024/11/1900.00137.4537.70-1661-0.15%
2024/11/14138.0000.0037.3016840.15%
2024/11/1100.00139.8040.00-1657-0.15%
2024/11/05540.7200.0040.2556830.73%
2024/10/2900.00341.6542.00-3736-0.41%
2024/10/21242.9500.0042.9528170.24%
2024/10/14143.8000.0043.7018950.11%
2024/10/08143.9500.0043.9519200.11%
2024/09/30345.4000.0045.2039550.31%
2024/09/27145.2000.0045.3519720.10%
2024/09/2000.00147.1046.35-11,141-0.09%
2024/09/11147.3000.0047.2511,1980.08%
2024/09/0600.00247.5547.60-21,245-0.16%
2024/08/3000.00149.2049.60-11,286-0.08%
2024/08/29248.8000.0048.9521,2880.16%
2024/08/2000.00149.5048.65-11,343-0.07%
2024/08/05141.0500.0041.0511,3220.08%
2024/08/020.545.8000.0045.600.51,2990.04%
2024/07/29646.7300.0046.0061,3140.46%
2024/07/182.549.8700.0049.702.51,2710.20%
2024/07/02255.000.255.0054.201.91,2600.15%
2024/07/01155.5000.0056.3011,2280.08%
2024/06/2800.00254.3055.00-21,182-0.17%
2024/06/27453.2000.0053.0041,1520.35%
2024/06/260.253.0000.0052.700.21,1310.01%
2024/06/18152.50153.1052.2001,1560.00%
2024/06/1700.00353.9753.70-31,145-0.26%
2024/06/1200.00252.3051.10-21,122-0.18%
2024/06/11152.50452.8052.10-31,124-0.27%
2024/06/0700.00251.3051.60-21,135-0.18%
2024/06/04550.9200.0050.5051,1970.42%
2024/06/03151.3000.0051.3011,2340.08%
2024/05/310.651.00351.5352.10-2.41,238-0.19%
2024/05/29251.3500.0051.6021,2420.16%
2024/05/280.151.30251.3051.30-1.91,245-0.16%
2024/05/27351.1000.0051.0031,2450.24%
2024/05/1600.00154.0053.90-11,261-0.08%
2024/05/151.152.51452.8052.40-31,258-0.23%
2024/05/1000.00154.1054.10-11,389-0.07%
2024/05/06153.9000.0053.6011,3960.07%
2024/05/0300.00152.5052.40-11,392-0.07%
2024/05/0200.00252.4552.30-21,409-0.14%
2024/04/30152.0000.0051.6011,4060.07%
2024/04/29551.5017749.6052.00-1721,408-12.21% 大賣/鉅額交易
2024/04/26251.6000.0051.3021,4110.14%
2024/04/2500.00152.9052.00-11,455-0.07%
2024/04/2400.00152.7052.50-11,468-0.07%
2024/04/19248.6000.0048.5021,5440.13%
2024/04/16148.5000.0048.5011,6020.06%
2024/04/15151.1000.0050.7011,5850.06%
2024/04/1100.00153.0052.10-11,584-0.06%
2024/04/10152.9000.0053.0011,5830.06%
2024/04/0900.00152.1052.10-11,581-0.06%
2024/04/0100.00252.8052.90-21,587-0.13%
2024/03/251053.3000.0053.50101,5960.63%
2024/03/22252.1500.0053.0021,5970.13%
2024/03/18154.0000.0054.0011,5980.06%
2024/03/11155.2000.0055.2011,7330.06%
2024/03/08157.50257.7057.50-11,760-0.06%
2024/03/07057.7300.0059.3001,8060.00%
2024/03/05259.7500.0059.3021,8110.11%
2024/03/043.160.0300.0060.003.11,8130.17%
2024/03/01160.90260.8060.80-11,815-0.06%
2024/02/29161.1000.0061.2011,8520.05%
2024/02/2700.00161.1061.40-11,854-0.05%
2024/02/2600.00161.4061.50-11,860-0.05%
2024/02/22161.0000.0060.8011,8590.05%
2024/02/191063.0000.0062.90101,8880.53%
2024/02/16262.00162.0062.5011,8900.05%
2024/02/05364.77464.8565.30-11,870-0.05%
高端疫苗 相關文章